These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16495925)

  • 21. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
    Fukagawa A; Ishii H; Miyazawa K; Saitoh M
    Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
    Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion.
    Chen D; Sun Y; Yuan Y; Han Z; Zhang P; Zhang J; You MJ; Teruya-Feldstein J; Wang M; Gupta S; Hung MC; Liang H; Ma L
    PLoS Genet; 2014 Feb; 10(2):e1004177. PubMed ID: 24586203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion.
    Kokura K; Sun L; Bedford MT; Fang J
    EMBO J; 2010 Nov; 29(21):3673-87. PubMed ID: 20871592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
    Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
    Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer cooperativity as a novel mechanism underlying the transcriptional regulation of E-cadherin during mesenchymal to epithelial transition.
    Alotaibi H; Basilicata MF; Shehwana H; Kosowan T; Schreck I; Braeutigam C; Konu O; Brabletz T; Stemmler MP
    Biochim Biophys Acta; 2015 Jun; 1849(6):731-42. PubMed ID: 25652130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
    Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
    J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.
    Dumont N; Wilson MB; Crawford YG; Reynolds PA; Sigaroudinia M; Tlsty TD
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14867-72. PubMed ID: 18806226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.
    Bolós V; Peinado H; Pérez-Moreno MA; Fraga MF; Esteller M; Cano A
    J Cell Sci; 2003 Feb; 116(Pt 3):499-511. PubMed ID: 12508111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
    Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
    World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
    Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
    Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.